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Erythrocytes of some  animal  species  are  lysed  by  human  serum  as  a  result  of 
activation of the alternate pathway of complement. This process may be modulated 
by the sialic acid content of the erythrocytes in the low levels of sialic acid favor lysis, 
whereas high levels of this sugar impede lysis (1-3). The sialic acid residues appear to 
function by favoring access of the fllH protein to bound complement convertase of 
the alternate complement pathway (C3bBb),~ a process that promotes decay-dissocia- 
tion  of the  C3  amplification  convertase,  thereby  preventing  amplification  of the 
alternate complement pathway (1, 2). Nydegger et al. (4) have reported that the sialic 
acid content of murine erythrocytes is determined by an autosomal locus, and that 
the resultant variation in surface sialic acid can explain the differences in susceptibility 
among inbred strains  to lysis  by human complement. In that study, the sialic acid 
content of the erythrocyte ghosts was determined by the thiobarbituric acid method 
of Warren (5), following mild acid hydrolysis. However, it was subsequently demon- 
strated that  murine erythrocyte sialic acids may contain  O-acetyi groups, which are 
known to interfere with the estimation of total sialic acid by the Warren method (6). 
We postulated that the genetic trait responsible for the differences in susceptibility of 
murine  erythrocytes to  lysis  by  human  complement  might  be  the  degree  of  O- 
acetylation of the sialic acid residues rather than the absolute content of sialic acid. 
The data presented in this paper are consistent with this proposal. 
Materials and Methods 
Inbred strains of mice were purchased  from The Jackson Laboratory  (Bar Harbor,  Maine). 
Recombinant  inbred  strains  (B  ×  D)  were provided by Dr.  Donald  Shreffier of Washington 
University (St. Louis, Mo.). These were originally obtained from Dr. Ben Taylor of The Jackson 
* Supported  in  part  by U. S.  Public Health Service  grant  R01  CA08759  and  National Institutes of 
Health grant T32 HL07088-05. 
1 Abbreviations used in  this paper: BHT, butylated hydroxytoluene; C3bBb, complement convertase of the 
alternate complement pathway; GLC, gas-liquid  chromatography; MBTH, 3-methyl-2-benzothiazolinone 
hydrazone hydrochloride; NeuNAc, N-acetylneuraminic acid; NeuNGI,  N-glycolyneuraminic acid;  PBS, 
phosphate-buffered  saline;  RBC, erythrocyte(s);  RI, recombinant  inbred;  SDS-PAGE, sodium  dodecyl 
sulphate-polyacrylamide gel electrophoresis;  TBA, thiobarbituric acid; TSIM, trimethylsilylimidazole: 7- 
O-Ac-NeuNAc, 7-O-acetyl-N-acetylneuraminic  acid; 9-O-Ac-NeuNAc, 9-O-acetyl-N-acetylneuraminic  acid. 
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Laboratory.  Vibrio cholerae neuraminidase was  from  Calbiochem-Behring Corp.,  American 
Hoechst Corp., San Diego, Calif. Butylated hydroxytoluene (BHT) was from Sigma Chemical 
Co. (St. Louis, Mo.), and 3-methyl-2-benzothiazolinone  hydrazone hydrochloride (MBTH) was 
from Eastman Kodak Co.  (Rochester, N.  Y.). AG analytical grade ion-exchange resins were 
obtained from Bio-Rad Laboratories (Richmond, Calif.) and trimethylsilylimidazole (TSIM) 
from Pierce Chemical Co.  (Rockford, Ill.).  3% OV-17 on Gas-Chrom Q,  100-200 mesh, was 
from Applied Science Laboratories (Waltham, Mass.). N-acetylneuraminic  acid (NeuNAc) and 
N-glycolylneuraminic  acid (NeuNGI) were from Sigma Chemical Co. Authentic 9-O-acetyI-N- 
acetylneuraminic acid  (9-O-Ac-NeuNAc)  was kindly provided by Dr.  Roland Sehauer, Kiel, 
Federal Republic of Germany. All other chemicals were of reagent grade. 
Preparation of Erythrocyte (RBC)  Ghosts. Blood was  collected by orbital sinus puncture into 
phosphate-buffered saline (PBS)  that contained 20 U  of heparin/ml. After centrifugation at 
1,500 g at room temperature for  15 min, the buffy coat, plasma, and upper one-fifth of the 
packed cells were removed, and the remaining RBC were washed twice with cold PBS.  The 
cells  were  then hemolysed with  15  vol of ice-cold  10 mM Tris buffer, pH  7.4, with  1 mM 
EDTA. The ghosts were sedimented at  10,000 g (4°C) for 10 rain and washed repeatedly until 
the stroma were free of any pink tinge. A final wash was made in distilled water.  10 ~1 of 1% 
BHT in ethanol was added to 20 ml of the final water wash if storage was necessary before 
analysis. 
Determination of Total Sialic Acid Content.  Samples of RBC ghosts  (200/~1) were incubated in 
0.1 N NaOH fro 45 min on ice to remove the O-acetyl groups of the sialic acid residues (6). The 
pH was then adjusted to  1.0 with HCI, and 2/~1 of 1% BHT in ethanol was added to inhibit 
lipid peroxidation during the subsequent acid hydrolysis. The samples were then hydrolyzed at 
80°C for  75 min. The released sialic acid was determined by the thiobarbituric acid (TBA) 
procedure of Warren (5). 
Estimation of the Extent of O-Acetylation of the Sialic Acid Residues.  For the reasons outlined in 
the Results, it was not possible to obtain conditions that allowed an exact determination of the 
extent of O-acetylation of the sialic acid residues. The following conditions were chosen because 
they allowed the best approximation of this value; these conditions were strictly adhered to 
throughout the study. Duplicate samples of ghosts  (200/~1) were adjusted to pH 2.0-2.1 with 
HCI, 2/.tl of 1% BHT was added, and the samples were hydrolyzed at 75°C for  75 min. Two 
similar samples were first subjected to de-O-acetylation in 0.1 N NaOH for 45 rain on ice and 
then brought to pH 2.0-2.1 with HCI and hydrolyzed as above. The released sialic acid was 
then measured by the Warren method (5). The increment in color formation observed when 
base treatment preceded acid hydrolysis was used to express the degree of O-acetylation of the 
sialic acids in the following way: O-acetylation index -- a -  b/a ×  100, where a equals sialic 
acid after base treatment and acid hydrolysis, and b equals sialic acid after acid hydrolysis only 
(6).  In every assay,  an  RBC  ghost  sample from  the  high  acetylation strain BUB/BnJ was 
included so that the other values could also be expressed  relative to this strain (arbitrarily set 
at  1.00). This was done to control for slight day-to-day fluctuations in the assay. 
Purification of Sialic Acids.  Sialic acids from bovine submaxillary muein and RBC  ghosts 
were isolated according to the method of Schauer (7). 
Analysis  of Sialic  Acids  by  Gas-Liquid  Chromatography.  The  procedure  of Schauer  (7)  was 
followed  with a few modifications. The purified sialie acids from bovine submaxillary mucin 
and authentic 9-O-Ac-NeuNAc were used as standards. Portions of each sample were pretreated 
with NH4OH, pH  11.0, on ice for 2 h to de-O-acetylate the sialic acids. The NH4OH was then 
removed by lyophilization. Direct trimethylsilylation of the samples was carried out with  15 
/~l of TSIM reagent at 65°C for 5 min. Aliquots of 3-5 ~1 were  chromatographed on  1.6-m 
columns of 3% OV-17 (2.0 mm inner diameter) in a F and M  402 gas chromatograph with a 
temperature program  from  200  to  250°C  at  2°C/min. A  correction  factor of 2.16  for  the 
decreased relative detector response of 9-O-Ac-NeuNAc compared with NeuNAc was made, 
based on the data of Casall-Stenzel et al. (8). 
Analysis of 9-O-AcNeuNAc  by the MBTH Assay.  A modification of the MBTH procedure of 
Massamiri et al. (9) was used to estimate 9-O-Ac-NeuNAc content, because this derivative gave 
no  color  formation  in  the  assay,  whereas  after  de-O-acetylation, it  reacted  identically to 
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the relative amount of 9-O-Ac-NeuNAc in a mixture of purified NeuNAc and 9-O-AcNeuNAc. 
The following procedure was followed: 355 ~1 of PBS (pH 7.3) and 20 ~1 of 2 mM NaIO4 were 
added to a  sample that  contained 5-20  nmole of total sialic acid in  25  ~1 of H20,  and  the 
reaction was allowed to proceed for 15 min on ice in the dark. Then, 90/xl of MBTH reagent 
(10 mM MBTH in 0.05 N HCI) was added, the mixture was vortexed, and allowed to stand at 
room temperature for 20 min. 90 ffl of 5% FeCI3 solution was added, the mixture shaken, and 
then left at room temperature for 15 rain. The A~25 was read against a similarly prepared blank 
solution and compared with a standard of 10 nmole NeuNAc. Similar 25-/xl samples were also 
treated with 25 ffl of 0.2 N  NaOH  on ice for  1 h, neutralized with 50 ~1 of 0,1  N  HCI, and 
subjected to a similar analysis. The increment in color formation with base treatment was taken 
to represent the amount of 9-O-Ae-NeuNAc in the mixture. 
Polyacrylamide Gel Electrophoresis in  the  Presence of Sodium Dodecyl Sulfate.  The  method  of 
Laemmli (10)  was used with the following modification: The pH of the separation gel was 
changed  to 8.0  to prevent possible de-O-acetylation of the sialic acids. With 200-300  #g of 
protein/gel and a  10% acrylamide concentration, relatively sharp resolution of Coomassie blue 
staining bands could be obtained. Gel slices (6 mm) were assayed for sialic acid content and O- 
acetylation as follows: For total sialic acid, the slices were incubated in 200 ~1 of 0.2 N NaOH 
on ice for 1 h. 45/~1 of 2 N HCI and 135 ~1 of H20 were added, and the mixture was incubated 
at 80°C  for 75  rain. 500/~1 of water was then added, and after mixing, 750-/xl aliquots were 
removed, concentrated, and assayed for sialic acid by the Warren method (5),  using a scaled 
down  modifications of the TBA  procedure.  The  chromophor was extracted  into  350  /zl of 
cyclohexanone, and  the absorbance was read in a  300-/xl microcuvette. This procedure was 
capable of easily detecting 400 pmole of sialic acid. To estimate O-acetylation, parallel gel slices 
were suspended in 1 ml of water and adjusted to pH 2.0 with formic acid. After incubation at 
75°C for 75 min, 730 btl was removed, evaporated to dryness three times to remove all traces of 
formic acid, and then the sialic acid content was determined. An estimate of the percent  O- 
acetylation of the sialic acid in each gel slice was made as described above. 
Determination of Protein.  The method of Lowry et al. (11) was used to estimate the protein 
content of the samples. 
Results 
Analysis of Variables in the Estimation of the Extent of O-Acetylation  of Glycosidically Bound 
Sialic Acids.  Our initial experiments were designed to determine the best method for 
quantitating the extent of O-acetylation of the RBC sialic acid residues. The approach 
used took advantage of the fact that  the O-acetylated species give a  decreased color 
yield  in  the  standard  TBA  procedure  of Warren  (5).  Because  O-acetyl  esters  are 
extremely labile at alkaline pH, pretreatment with base will result in maximum color 
formation  (6,  12). This increment in color yield following alkaline treatment  can be 
used to estimate the extent of O-acetylation of the sialic acid residues. The procedure 
can be carried out on free or bound sialic acids. In agreement with previous reports, 
we found that treatment of RBC ghosts with 0.1 N  NaOH  for 45 min at 4°C resulted 
in complete removal of O-acetyl groups from the bound sialic acids, yielding maximum 
color formation in the TBA assay. This increment has been previously used to obtain 
a  de-O~acetylation index (6). 
We found, however, that numerous variables prevented an accurate measurement 
of the absolute amount  of O-acetylation of the sialic acid residues in the membrane 
preparations.  Some of these are demonstrated  in Fig.  1.  The TBA assay of Warren 
requires prior cleavage of the glycosidic bond, which  is conventionally achieved by 
acid hydrolysis at pH  1.0 or 2.0 for  1 h  at 80°C.  As shown  in Fig.  1 A, hydrolysis at 
pH  1.1  at  75°C resulted in considerable de-O-acetylation (i.e., minimal increment in 
color yield with  base  treatment),  whereas  hydrolysis at  pH  2.2  (Fig.  1 B)  led  to  a 
selective release of non-O-acetylated species because these are more acid labile than AJIT VARKI AND  STUART KORNFELD  535 
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Fi6.  1.  Variables  in the estimation  of the degree of O-acetylation in the sialic acids of murine 
RBC.  A  pooled  sample  of RBC  ghosts from  strain C56BL/6J  was  used.  Large  aliquots  were 
subjected to de-O-acetylation (0.1 N NaOH on ice for 45 min) before or after acid hydrolysis under 
several different conditions, in the range 0.2-0.005 N HCI. Similar samples were also subjected to 
acid hydrolysis alone. The actual pH of the samples was checked at each step. Equal samples were 
assayed in duplicate for color formation  by the TBA reaction  at several time intervals.  Upper 
panels:  Sialic acid measured  by the TBA assay. (O)  acid hydrolysis alone;  (O)  acid hydrolysis 
followed by base treatment; and (×) base treatment followed by acid hydrolysis. Lower panels: O- 
acetylation  index for each time point and sequence =  a -  b/a x  100. (a equals sialic acid value 
when base treatment was before (') or after (I-1) acid hydrolysis, b equals sialic acid value with no 
base treatment.) 
the O-acetylated species (13,  14). With prolonged hydrolysis at pH 2.2, de-O-acetyla- 
tion occurred as indicated by the decrease in the acetylation index (Fig.  1 B, bottom). 
After several experiments similar to thse shown  in Fig.  1, we were unable to find 
ideal conditions for the accurate estimation of the degree of O-acetylation in a  given 
specimen.  The  conditions  that  we  used  (Materials  and  Methods)  represented  an 
attempt to release most of the sialic acid residues with a minimum ofde-O-acetylation. 
Even though these conditions were rigidly adhered to throughout the study, there was 
some variation in the acetylation index during repeated assays, most likely because of 
factors such as slight pH differences and fluctuations in the temperature of the heating 
block. For this reason every assay for the acetylation index included a specimen from 
the high acetylation strain BUB/BnJ  as an internal control. This value could be set 
to  1.0 and others related to it. 
This  O-acetylation index significantly underestimates  the absolute amount  of O- 
acetylation in mouse RBC sialic acids. This is because 9-O-AcNeuNAc, which is the 
major O-acetylated species (see below), gives a  50% color reaction in the TBA assay 
before de-O-acetylation (7). 
Comparison of Total and O-Acetylated Sialic Acid in RBC of Various Murine Strains.  As 536  O-ACETYLATION  OF  SIALIC  ACIDS  AND  COMPLEMENT  ACTIVATION 
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FIG.  2.  Sialic acids of murine RBC ghosts: relationship to capacity of intact RBC to activate the 
human alternate pathway of complement (data of Nydegger et al.  [4]).  Upper Panel:  Sialic acids 
measured by the TBA assay with (O)  and without (0) prior base treatment. Lower panel:  Degree 
of O-acetylation of sialic acids relative to strain BUB/BnJ. Calculated from the data in the upper 
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O-acetylat  ion 
Murine  Complement  O-acetylation  relative  to 
strain  activating  Sialic  acid content  index  strain 
capacity*  BUB/BnJ 
U  nmol/mg protein 
BUB/BnJ  85 ±  l  65 + 4  (5)  67 ± 7 (12)  1.00 
C57BL/6J  69 ± 6  64 ±  10 (5)  68 ± 5 (5)  0.98 ± 0.08 
A/J  42 ± 5  68 ±  17 (4)  56 ± 5 (4)  0.81 ± 0.07 
DBA/2J  33 ± 2  64 ± 8  49 ± 7 (4)  ND, 
AKR/J  28±3  70±4  (6)  46± 7(10)  0.73±0.16 
ST/bJ  26 ± 4  52 ±  14 (5)  47 ± 8 (5)  0.67 ± 0.12 
All  values are mean  ±  SD.  Figures in  parentheses represent total  number  of 
experiments. The actual data points are shown in Fig. 2. ND, not done. 
* Data of Nydegger et al. (4). 
shown in Fig.  2 and Table I, the quantity of sialic acid per milligram  of membrane 
protein  was similar in all the strains studied.  In contrast, the extent of O-acetylation 
of the  sialic  acid  residues  was significantly  different  among the  strains  and  bore  a 
direct  relationship  to  the  capacity  of the  RBC  to  activate  the  human  alternate 
pathway  of complement  (Table  I).  This  relationship  held  whether  the  data  were 
expressed as the acetylation index or as O-acetylation relative to strain BUB/BnJ. 
Characterization of the O-Acetylated  Acid Species.  Sialic acids may be O-acetylated at 
positions 4, 7, 8, and 9  (7).  Consequently, the differences between the murine strains 
in the extent of O-acetylation of the sialic acid residues could reflect either quantitative 
differences in the amount of a particular O-acetylated species, or qualitative differences 
in  the  types  of O-acetylated  species.  For  instance,  strains  with  high  degrees  of O- 
acetylation could have two types of O-acetylated sialic acids, whereas strains with low 
percentages of O-acetylated species could have only one of these types. To resolve this 
point, sialic acids were released by mild acid from C56BL/6J, A/J, and ST/bJ  RBC 
ghosts, purified, and analyzed by gas-liquid chromatography (GLC). Some examples 
of the scans of the GLC analyses are shown in Fig. 3. All of the strains had, in addition 
to NeuNAc, a peak that eluted with an RNe,NAc identical to standard 9-O-Ac-NeuNAc 
(Fig.  3A  and  B).  This  peak  disappeared  after  mild  base  treatment  (Fig.  3C)  as 
expected for an O-acetylated species. The small peak that corresponded in location to 
7-O-acetyl-N-acetylneuramininic  acid  (7-O-Ac-NeuNAc)  was  not  affected  by  base 
treatment  and, therefore, does not represent  an O-acetylated sialic acid. 
Because it is known that the relative detector response (RDR)  to 9-O-Ac-NeuNAc 
is less than  that  to an equimolar amount of NeuNAc, we used  the correction factor 
reported  by  Casal-Stenzel  et  al.  (8)  when  computing  the  percentage  of 9-O-Ac- 
NeuNAc in  each sample.  The corrected  and  uncorrected  values  for each  strain  are 
presented  in Table II along with  the acetylation  index  for the starting  RBC ghosts. 
The estimate  of the  percentage  of 9-O-Ac-NeuNAc derived  from the GLC analysis 
follows that predicted by the acetylation index. The values are somewhat lower than 
expected, most likely because of some de-O-acetylation that is known to occur during 
purification of the sialic acid species (7). We also used the MBTH procedure described 
by Massamiri  et  al.  (9)  for estimating the percent  9-O-Ac-NeuNAc in purified sialic 
acid preparations.  This assay depends upon the quantitative  release by periodate of 538  O-ACETYLATION OF  SIALIC ACIDS  AND COMPLEMENT ACTIVATION 
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I"lo. 3.  Identification of O-acetyl substitution in sialic acids of murine RBC ghosts. GLC of purified 
sialic acids from murine RBC ghosts and bovine submaxillary mucin on OV-17 (3~). Temperature 
program started at 200°C at 2°C/rain (Materials and Methods). A, sialic acids from strain ST/bJ. 
B, sialic acids from strain C56BL/6J.  C, sialic acids from strain A/J, de-O-acetylated with base 
treatment.  D, sialic acids from bovine submaxillary mucin. Peak 1, NeuNAc; 2, 9-O-Ac-NeuNAc; 
3, 7-O-Ac-NeuNAc;  4, NeuNGI. 
the 9-carbon of NeuNAc as formaldehyde. When this carbon is blocked, as in 9-O-Ac- 
NeuNAc,  no  reaction  occurs,  but  a  complete reaction  can  be  obtained  after  de-O- 
acetylation with mild base. This increment in color formation following base treatment 
can be used to assay the amount of 9-O-Ac-NeuNAc in a purified mixture of NeuNAc 
and 9-O-Ac-NeuNAc. As shown in Table II, the values obtained with this method are 
in good agreement with those obtained by the GLC analysis. We conclude from these 
studies that 9-O-Ac-NeuNAc is the predominant O-acetylated species in both the high AJIT VARKI AND STUART KORNFELD 
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Starting RBC ghosts 
Murine  Total sialic  strain  Total sialic  Acetylation  acid 
acid  index  recovered 
Purified sialic acids 
Percent 9-O-Ac-NeuNAc 
By GLC 
Area  Corrected* 
By 
MBTH 
method 
nmol  nmol 
C57BL/6J  956  59  651  30  47  39 
A/J  1,314  50  1,177  21  35  25 
ST/bJ  945  38  567  16  29  22 
The techniques for purifying the sialic acids and  for analyzing them by GLC and the 
MBTH method are described in Materials and Methods. 
* The correction factor for the  decrease in  RDR of 9-O-Ac-NeuNAc with a  3% OV-17 
column (1.6 m ×  2 mm inner diameter) was taken from CasaI-Stenzel et al.  (8). RDR 
NeuNAc/RDR 9-O-Ac-NeuNAc  = 2.16. 
and low acetylation strains of mice. 
Distribution  of  O-Acetylated  Sialic  Acids  among  the  Glycoproteins  of  the  Murine 
RBC.  Another possible  mechanism  for the observed differences  in the extent  of O- 
acetylation  of the  sialic  acid  residues  could  be  that  there  are  differences  in  the 
glycoprotein content  of RBC  from the various murine strains,  and that  these glyco- 
proteins  have different  percentages  of O-acetylated sialic  acid residues.  To examine 
this  possibility,  RBC  ghosts from BUB/BnJ  and AKR/J  were subjected  to sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis  (SDS-PAGE)  to separate  the gly- 
coproteins. The gels were then frozen and sliced, and the slices were tested directly for 
total  sialic  acid  content  and  the  extent  of O-acetylation.  As  shown  in  Fig.  4,  O- 
acetylated sialic acids were distributed  throughout the gel, although to an increasing 
extent toward the cathodal end. The difference in the degree of O-acetylation between 
the high and low strains was clearly seen and was present  in all sections of the gel. 
Pattern of Inheritance of the Differences in  O-Acetylation.  To  establish  the  pattern  of 
inheritance of these differences in 9-O-acetylation of the RBC sialic acids, we studied 
the  progeny of C56BL/6J  (high acetylation)  and  DBA/2J  (low acetylation)  strains. 
As shown in Fig. 5, all samples from the B6.D2/F 1J hybrids showed a high acetylation 
index,  which  suggested  an  autosomal  dominant  pattern  of inheritance.  To  further 
substantiate this, and to attempt to map the locus involved, we studied  14 recombinant 
inbred strains (B X D) originally derived from B6.D2/F1J hybrids (15). Each of these 
strains was derived by systematic inbreeding from the cross of two individual B6.D2/ 
F1J  (15).  As  expected  for  an  autosomal  dominant  trait  (15),  the  B  X  D  strains 
segregated into high acetylation (six)  and low acetylation (eight) strains  (Fig. 5). This 
provides evidence for a  single autosomal dominant genetic locus. 
To map this locus to a  specific chromosomal site, we compared this data with the 
previously available information regarding the chromosomal mapping of other known 
genes  among  the  B  ×  D  strains  (15).  Gene  d,  on  chromosome  9,  showed  only  2 
discrepancies in the 14 strains examined. The adjacent genes, Sep-I  and Mod-I showed 
3 and 4 discrepancies out of 14, respectively. This level of concordance was not found 
in any other region of the chromosomal map. These results  make it  very likely that 540  O-ACETYLATION  OF  SIALIC  ACIDS  AND  COMPLEMENT  ACTIVATION 
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FIG.  4.  Distribution of the O-acetylated sialic acids among the murine RBC ghosts glycoproteins. 
RBC ghosts were prepared, extracted, and subjected to SDS-PAGE gel electrophoresis as described 
in Materials and Methods; 6-mm gels slices (~ 125-/.tl vol each) were analyzed for sialic acid content 
with  and  without  prior  base  treatment.  The  sialic  acids  were  released  by  acid  hydrolysis and 
concentrated  for analysis as described in  Materials and Methods. (~  indicates the position of the 
bromophenol blue marker.  (A)  300/.tg of ghost protein from strain BUB/BnJ that contained 22.4 
nmol of sialic acids was applied to the gel. The sum of the sialic acids measured in all the slices was 
20 nmo[ (89.3%  recovery). (B) 300 ag of ghost protein from strain AKR/J that contained 20.1  nmol 
of sialic acid was applied to the gel. The sum of the sialic acids measured in all slices was 17.2 nmol 
(85.4'7,,,). The area within the hatched bars I~rrepresents sialic acids measured in each gel slice after 
acid  hydrolysis only. The clear  area []  shows the  increment  in  sialic acids  measured after  base 
treatment.  (C)  Estimation of the extent of O-acetylation of the sialic acids in  the individual gel 
slices. This value represents the percent increment after base treatment and was calculated from the 
data in panels A and B+ m, BUB/BnJ; E], AKR/J. AJIT  VARKI  AND  STUART  KORNFELD 
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Fic.  5.  Distribution of high and low O-aeetylation of RBC sialic acids among F~ and stable RI (B 
×  D) progeny of C56BL/6J and DBA/2J.  Mean values of O-acetylatio  n  index of RBC sialic acids 
of murine strains as noted. RI strains (B X D) in order (from top to bottom) are B ×  D-l, B ×  D-I 1, 
B ×  D-28, B X D-27, and B ×  D-24 (high strains) and B x  D-5, B ×  D-30, B ×' D-12, B ×  D-16, B" 
×  D-25, B ×  D-21, B ×  D-18, and B x  D-6 (low strains). 
the gene modulating O-acetylation of sialic acid is located on chromosome 9, close to 
gene d. 
Discussion 
The elegant studies of Fearon, Austin, and others have clearly demonstrated a role 
for surface  sialic  acid  in  permitting  access  of the  /~IH  protein  to  bound  C3bBb, 
thereby  preventing amplification  of the  alternate  pathway  of complement  (1,  2). 
Furthermore, these  investigators showed by periodate degradation  that  it  was  the 
exocyclic hydroxyl groups on .the 8 and 9 carbons of sialic acid that were vital to this 
function (1).  It is reasonable to hypothesize that the presence of varying amounts of 542  O-ACETYLATION  OF SIALIC ACIDS AND COMPLEMENT ACTIVATION 
O-acetylation in the 9-carbon position of surface sialic acids could result in varying 
degrees of activation of the alternate complement pathway. Our  finding of a  good 
correlation between the degree of 9-O-acetylation of the sialic acids of murine RBC 
and their capacity to activate the alternate pathway of human complement strongly 
supports  this  postulation.  RBC  from  the  strains  with  the  highest  degree  of 9-0- 
acetylation  are  the  most  sensitive  to  complement  lysis,  presumably  reflecting  the 
impaired binding of the fllH protein. 
Nydegger et al.  (4)  reported an inverse correlation between the quantity of sialic 
acid  on  the  surface  of murine  RBC  and  the  sensitivity  to  lysis  by  the  alternate 
complement pathway. However, the interference caused by O-acetylation of the sialic 
acids in the conventional TBA assay could not be taken into account. We found no 
significant difference in the total quantity of sialic acids in RBC of several of these 
murine strains when base treatment was done before acid hydrolysis to eliminate the 
interfering O-acetyl groups. 
We conclude that the autosomal locus, which determines sensitivity to complement 
lysis,  regulates the extent of 9-O-acetylation of the  RBC  sialic acid  residues rather 
than the quantity of RBC sialic acid. These findings, taken with those by Nydegger 
et al.  (4) indicate that membrane-associated NeuNAc residues, with unmodified C7- 
9 polyhydroxylated side chains, are critical in preventing human alternative comple- 
ment pathway activation. Our studies of the segregation of high and low O-acetylation 
in recombinant inbred (RI) strains supports control of this trait by a single autosomal 
dominant  genetic locus on chromosome 9.  However, the nature of the gene product 
of this locus is not evident from our studies. Because both high and low O-acetylation 
strains contain 9-O-Ac-NeuNAc, the gene product is unlikely to be the 9-O-acetylating 
enzyme. Many factors could potentially modulate the extent of 9-O-acetylation and 
de-O-acetylation of the  sialic  acid  residues  (for a  review of the  metabolism  of O- 
acetylation of sialic acids, see Schauer [16]). The postulated gene product could act at 
any of these steps. 
Our  findings  might  also  explain  the  previously described  polymorphism  in  the 
electrophoretic mobility  and  the  nonspecific agglutinability  of murine  RBC  (17). 
With a few exceptions, these two characteristics segregate in a predictable manner in 
relation to the sensitivity to complement lysis and the polymorphism in the extent of 
O-acetylation  of the  sialic  acid  residues.  Because  surface  sialic  acid  is  the  major 
determinant of the electrophoretic mobility of RBC  (18), varying degrees of substi- 
tution at the 9 position could alter the net charge to a minor degree, which could be 
sufficient to explain the small differences observed in electrophoretic mobility. Like- 
wise, because nonspecific agglutinability by polybrene is probably related to partial 
neutralization of surface charge, RBC with the greatest extent of O-acetylated sialic 
acid might be the most easily agglutinated by this reagent. 
The finding that 9-O-Ac-NeuAc acid is the major sialic acid derivative in murine 
RBC  agrees  with  the  results  of Howard  and  Schauer  with  BALB/c  mice  (R.  J. 
Howard and R. Schaurer. Personal communication.). These investigators also detected 
small quantities of an unidentified di-O-acetyl species. We were unable to demonstrate 
the presence of several other O-acetylated species reported by Sarris and Palade (6). 
A  recent report by Howard  (19)  indicates that  environmental factors, as well as 
genetic factors, may influence the O-acetylation of murine RBC sialic acid residues. 
Howard found that during Plasmodium berghii infection in BALB/c mice there appeared AJIT VARKI AND STUART  KORNFELD  543 
to be a marked increase in the extent of O-acetylation of surface sialic as evidenced by 
the  almost  complete  loss  of periodate/NaB[aH]4  labeling  of surface  glycoproteins 
without any actual loss of the sialic acid residues. In preliminary experiments we have 
noted that repeated bleeding or hemolysis produced by phenylhydrazine appeared to 
result in increased O-acetylation in the low acetylation strains. The biological signif- 
icance of these changes is as yet, unclear. 
StllTlrnary 
Nydegger et al. (4) have reported that the difference in susceptibility oferythrocytes 
from different  inbred  murine  strains  to  lysis by the  human  alternate complement 
pathway is determined  by an  autosomal  locus.  We have found a  good correlation 
between  the  degree of O-acetylation of the erythrocyte sialic acid  residues  and  the 
susceptibility  to complement  lysis, whereas  there  was no correlation  between  total 
erythrocyte sialic acid content  and complement sensitivity. The major O-acetylated 
species in all the murine strains is 9-O-acetyl-N-acetylneuraminic acid. 
We  propose that  the  autosomal  dominant  locus,  which  determines  complement 
sensitivity, acts by influencing the extent of 9-O-acetylation of the erythrocyte sialic 
acid residues.  By using recombinant inbred strains, we determined that this genetic 
locus is probably located on chromosome 9. The nature of the gene product remains 
unknown. 
The authors wish to thank Dr. Donald Shreffler and Dr. Rosalind Kornfeld for their help and 
advice. 
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